Julie Fitzgerald to Precursor Cell Lymphoblastic Leukemia-Lymphoma
This is a "connection" page, showing publications Julie Fitzgerald has written about Precursor Cell Lymphoblastic Leukemia-Lymphoma.
Connection Strength
0.870
-
Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia. Crit Care Med. 2017 Feb; 45(2):e124-e131.
Score: 0.441
-
Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy. Nat Rev Clin Oncol. 2019 01; 16(1):45-63.
Score: 0.126
-
Supportive care utilization and treatment toxicity in children with Down syndrome and acute lymphoid leukaemia at free-standing paediatric hospitals in the United States. Br J Haematol. 2016 08; 174(4):591-9.
Score: 0.105
-
Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia. Cancer Discov. 2016 06; 6(6):664-79.
Score: 0.104
-
Association of weekend admission with hospital length of stay, time to chemotherapy, and risk for respiratory failure in pediatric patients with newly diagnosed leukemia at freestanding US children's hospitals. JAMA Pediatr. 2014 Oct; 168(10):925-31.
Score: 0.094